LENZ Therapeutics enters into $150M ATM sales agreement with TD Cowen

LENZ Therapeutics, Inc.

Company entered Sales Agreement with TD Securities (USA) LLC to sell up to $150M common stock via ATM offering.
TD Cowen will act as sales agent and receive up to 3.0% of gross proceeds from shares sold.
Shares will be issued under shelf registration statement on Form S-3 filed April 4, 2025.
Company has no obligation to sell shares and may suspend offerings at any time.
Agreement can be terminated by either party on 10 days' notice or immediately under certain conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.